Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study.
- Resource Type
- Article
- Source
- Human Vaccines & Immunotherapeutics; 2019, Vol. 15 Issue 5, p1066-1069, 4p
- Subject
- Language
- ISSN
- 21645515